If you want to know who really controls Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), then you'll have to look at the makeup of its share registry. And the group that holds the bi ...

Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

Speculation is in, conservatism is out as retail investors bid up questionable assets and imaginative financing exploits the ...

Q2 2025 Earnings Call Transcript July 24, 2025 Dover Corporation misses on earnings expectations. Reported EPS is $2.02 EPS, ...

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in ...

Some of the biggest players in artificial intelligence continued to ramp up their spending on federal lobbying last quarter, ...